Tekla Capital Management LLC Abiomed Inc Transaction History

Tekla Capital Management LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$285.92 - $355.13 $3.09 Million - $3.84 Million	-10,812 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$251.88 - $324.2 $352,632 - $453,880	-1,400 Reduced 11.46%	10,812 $3.51 Million
Q3 2020 Nov 13, 2020	SELL	$255.22 - $317.0 $914,198 - $1.14 Million	-3,582 Reduced 22.68%	12,212 $3.38 Million
Q2 2020 Aug 13, 2020	SELL	$141.4 - $257.09 $1.94 Million - $3.53 Million	-13,722 Reduced 46.49%	15,794 $3.82 Million
Q1 2020 May 14, 2020	SELL	$130.51 - $196.01 $417,632 - $627,232	-3,200 Reduced 9.78%	29,516 $4.29 Million
Q2 2019 Aug 14, 2019	BUY	$250.96 - $284.94 $2.19 Million - $2.49 Million	8,730 Added 36.4%	32,716 $8.52 Million
Q1 2019 May 14, 2019	BUY	$276.39 - $362.25 $3.22 Million - $4.22 Million	11,636 Added 94.22%	23,986 $6.85 Million
Q4 2018 Feb 13, 2019	BUY	$281.08 - $444.25 $2.42 Million - $3.82 Million	8,600 Added 229.33%	12,350 $4.01 Million
Q3 2018 Nov 13, 2018	BUY	$354.53 - $449.75 $1.33 Million - $1.69 Million	3,750 New	3,750 $1.69 Million
Q2 2018 Aug 13, 2018	SELL	$278.07 - $446.21 $1.81 Million - $2.91 Million	-6,514 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$192.49 - $295.85 $1.25 Million - $1.93 Million	6,514 New	6,514 $1.9 Million

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Tekla Capital Management LLC with notifications on news.